The settlement closes a coverage fight over PFAS claims, after a court distinguished firefighter exposure suits from water contamination cases.
The settlement between National Foam and insurers led by Zurich American ends a dispute over how liability policies respond to PFAS claims. It leaves a question for future cases: whether alleged harm arose from ordinary product use or from pollution. That distinction can determine whether an insurer must provide a legal defense, even when the same chemical is involved.
The parties agreed Thursday to dismiss all claims in National Foam Inc. v. Zurich American Insurance Company, with each side covering its own fees and costs. They didn’t disclose the settlement terms, so the agreement offers no public answer on how they valued the coverage dispute or whether either side changed its view of the underlying claims. A trial had been scheduled for December 2027. Axa XL and American International Group units were also named as insurers.
A split ruling on defense coverage
The last major decision came in 2025, when a judge in the U.S. District Court for the Northern District of California in San Francisco held that insurers had to defend National Foam against claims by firefighters alleging harm from using its foam. The ruling didn’t extend that duty to suits alleging contamination of water supplies. The split turned on the alleged pathway of exposure, not simply on whether PFAS was present.
The case involved aqueous film-forming foam, which contains perfluoroalkyl and polyfluoroalkyl substances, or PFAS. National Foam, based in Exton, Pennsylvania, faces thousands of lawsuits over the products. Most are consolidated in a federal multidistrict litigation in South Carolina, a process that groups related cases for coordinated pretrial proceedings. The company had sought a ruling requiring insurers to defend every direct-exposure claim, including at least 182 identified cases.
Applying California law, the judge found that the policies’ pollution exclusion didn’t clearly cover injuries allegedly caused by ordinary use of the foam. The exclusion applies to injury from the “discharge, dispersal, seepage, migration, release or escape” of pollutants, but the judge said the mechanism of harm matters as well as the substance involved. That reading makes the policy language do more than classify a chemical; it asks how the alleged injury occurred.
“Courts recognize that ‘pollution’ is not just a class of substances (i.e., ‘smoke, vapor, soot, fumes, acids, alkalis, chemicals, and waste’), but also a mechanism of harm,” she wrote. Citing a pesticide case involving the alleged death of a tenant, she said that although the alleged harm involved a chemical, “the mechanism of harm was not pollution.” The analogy underscores a practical problem for insurers and policyholders: a broad exclusion tied to substances can reach far beyond the environmental contamination claims that may have prompted it.
The judge also pointed to the breadth of treating every chemical-related injury as pollution. National Foam is a chemical maker, she observed; under that interpretation, it was unclear “what, if anything, would be covered by the policy in the carriers’ view.” This is more significant than it looks: an exclusion read too broadly can leave a business with little meaningful protection for claims connected to its ordinary products.
Coverage boundaries remain case specific
The ruling stopped short of requiring a defense across all 182 direct-exposure cases. National Foam hadn’t established that each claim fell within the policies, and the judge noted that the multidistrict litigation court had ruled the company could not be liable for sales before it began operations in June 2013. The source identifies the company as National Foam but refers to “National Farm” in describing that date. The limitation matters because a favorable coverage ruling on one set of allegations doesn’t automatically resolve claims with different products, time periods or exposure theories.
For water-related claims, the judge found the pollution exclusion applied in a city’s suit over contamination of its water system and in a separate suit alleging exposure through drinking water. That distinction shaped the coverage dispute: firefighter claims tied to product use received a defense, while the cited contamination claims didn’t. A duty to defend is also a narrower question than ultimate responsibility for alleged injuries; the ruling addressed the insurers’ obligation to fund a defense under the policies, not whether the underlying claims were proven.
The broader firefighting-foam litigation has already produced billions of dollars in settlements. In 2023 and 2024, foam makers including 3M, DuPont and Tyco settled claims concerning contamination of public water systems. Those settlements show the financial scale of the disputes, but they don’t establish how every insurer’s policy applies to every claim. Coverage still turns on policy wording, governing law and the allegations in each case.
PFAS litigation also spans suits brought by state attorneys general and claims involving consumer products. The U.S. Environmental Protection Agency says PFAS has been widely detected in drinking water, fish and human blood, and has classified the chemicals as “likely to be carcinogenic to humans.” Those points help explain why the claims carry substantial stakes, but the coverage question remains distinct from the scientific and liability questions in the underlying litigation.
What the settlement leaves for future disputes
With the National Foam dispute dismissed and its terms undisclosed, the 2025 ruling remains the clearest account in this case of how alleged exposure pathways can affect insurers’ defense obligations. The settlement resolves the parties’ claims against one another, but it doesn’t supply a public ruling on the full set of direct-exposure cases or establish a universal rule for PFAS coverage. Here’s the thing: the same product can generate claims that fall on different sides of a pollution exclusion, depending on how plaintiffs describe exposure and injury.
If you’re working in this space, the case is a reminder that broad labels can obscure the details that drive coverage. Similar disputes typically turn on the policy text and the specific allegations, so a ruling based on one exposure pathway may offer limited guidance for another. And yet, the court’s reasoning gives policyholders a clear argument to press when an insurer treats every chemical-related injury as pollution. The unresolved boundary. Until the settlement terms or later decisions clarify more, that boundary will remain case specific.
Discussion
Sign in to join the discussion.